Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 159,074
- Value
- $40.0M
- % of portfolio
- 1.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 159,074 | $40.0M | 1.7% | −1,717−1.1% | Reduced | Holders |
| Q1 2026 | 160,791 | $35.0M | 1.8% | +3,415+2.2% | Added | Holders |
| Q4 2025 | 157,376 | $36.0M | 1.8% | −1,541−1.0% | Reduced | Holders |
| Q3 2025 | 158,917 | $36.8M | 1.9% | +4,911+3.2% | Added | Holders |
| Q2 2025 | 154,006 | $28.6M | 1.7% | +3,083+2.0% | Added | Holders |
| Q1 2025 | 150,923 | $31.6M | 2.1% | −19,257−11.3% | Reduced | Holders |
| Q4 2024 | 170,180 | $30.2M | 1.9% | +1,383+0.8% | Added | Holders |
| Q3 2024 | 168,797 | $33.3M | 2.2% | +3,548+2.1% | Added | Holders |
| Q2 2024 | 165,249 | $28.3M | 2.0% | +8,245+5.3% | Added | Holders |
| Q1 2024 | 157,004 | $28.6M | 2.2% | −53,544−25.4% | Reduced | Holders |
| Q4 2023 | 210,548 | $32.6M | 2.1% | +3,815+1.8% | Added | Holders |
| Q3 2023 | 206,733 | $30.8M | 2.3% | +5,935+3.0% | Added | Holders |
| Q2 2023 | 200,798 | $27.1M | 2.0% | +949+0.5% | Added | Holders |
| Q1 2023 | 199,849 | $31.8M | 2.5% | +5,145+2.6% | Added | Holders |
| Q4 2022 | 194,704 | $31.5M | 2.7% | +889+0.5% | Added | Holders |
| Q3 2022 | 193,815 | $26.0M | 2.4% | +1,337+0.7% | Added | Holders |
| Q2 2022 | 192,478 | $29.5M | 2.6% | +5,945+3.2% | Added | Holders |
| Q1 2022 | 186,533 | $30.2M | 2.3% | −42,408−18.5% | Reduced | Holders |
| Q4 2021 | 228,941 | $31.0M | 2.2% | +2,325+1.0% | Added | Holders |
| Q3 2021 | 226,616 | $24.4M | 1.9% | +4,427+2.0% | Added | Holders |
| Q2 2021 | 222,189 | $25.0M | 2.0% | +207+0.1% | Added | Holders |
| Q1 2021 | 221,982 | $24.0M | 2.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.